FDA Approved: NITROGLYCERIN IN DEXTROSE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved Baxter's supplemental application for Nitroglycerin in Dextrose, approving a nitroglycerin-in-dextrose intravenous formulation under NDA 019970.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Ischemic Heart Disease

Drugs mentioned

• NITROGLYCERIN IN DEXTROSE (Nitroglycerin)

Snippet

SUPPL AP for NITROGLYCERIN IN DEXTROSE (NITROGLYCERIN)